Patent Assignment
Reel/Frame 062403/0301
Assignment of Assignor's Interest
Recorded: 2023-01-17
Pages: 26
Assignor
HORIZON PHARMA RHEUMATOLOGY LLC
Executed: 2020-03-31
Assignee
HORIZON THERAPEUTICS USA, INC.
1 HORIZON WAY, DEERFIELD, ILLINOIS, 60015
Covered Property
(1)
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Jan 5, 2023
From: HORIZON PHARMA USA RHEUMATOLOGY LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 062594/0121 →
Assignment of Assignor's Interest
Jan 5, 2023
From: ROSARIO-JANSEN, THERESA; WRIGHT, DAVID ERICK
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 062279/0574 →
Assignment of Assignor's Interest
Jan 5, 2023
From: SAVIENT PHARMACEUTICALS, INC.; SAVIENT PHARMA HOLDINGS, INC.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 062294/0044 →
Change of Name
Jan 5, 2023
From: CREALTA PHARMACEUTICALS LLC
To: HORIZON PHARMA USA RHEUMATOLOGY LLC
Reel/Frame 062294/0095 →